Regencell Bioscience Holdings (RGC) Assets Average (2025)
Regencell Bioscience Holdings' (RGC) quarterly Assets Average came in at $4.4 million in Q4 2025.
Powered by 
Analysis
Regencell Bioscience Holdings (RGC) Assets Average (2025) Analysis & Trends
Regencell Bioscience Holdings (RGC) has reported Assets Average for 1 consecutive years, with $4.4 million the latest figure, recorded in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 200.98 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 135.79 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 129.24 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 120.28 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 204.57 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 149.95 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 3.29 Bn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 7.61 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 6.97 Bn |
| 10 | Regencell Bioscience Holdings | 76.52 Mn | 74.16 Mn | - | 4.38 Mn |